Sven-Ove Ogren

Title: The Innovations of Sven-Ove Ogren

Introduction

Sven-Ove Ogren is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating depressive states. His work has led to the filing of a patent that showcases his innovative approach to medicinal chemistry.

Latest Patents

Ogren holds a patent for "Compounds of diphenylcyclopentylamine type and methods for their preparation." This patent includes compounds of a specific formula and pharmaceutically acceptable salts thereof. The compounds are characterized by various substituents, including hydrogen atoms, chloro, or methoxy groups. The patent outlines processes for their preparation, pharmaceutical preparations containing these compounds, and their use in treating depressive states. Ogren's patent is a testament to his dedication to advancing medical science and improving patient outcomes. He has 1 patent to his name.

Career Highlights

Sven-Ove Ogren has been associated with Astra Lakemedel Aktiebolaget, a company known for its focus on pharmaceutical innovations. His work at the company has allowed him to explore and develop new therapeutic compounds that address mental health issues. Ogren's career reflects a commitment to research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Ogren has collaborated with esteemed colleagues, including Bernt Sigfrid Carnmalm and Ulf H Lindberg. These collaborations have likely contributed to the success of his projects and the advancement of their shared goals in pharmaceutical research.

Conclusion

Sven-Ove Ogren's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight his role as a significant inventor in the industry. His work continues to impact the treatment of depressive states, showcasing the importance of innovation in medicine.